Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin

This publication has 26 references indexed in Scilit:

• Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
  Medicinal Research Reviews, 1998
• XRCC2 and XRCC3, New Human Rad51-Family Members, Promote Chromosome Stability and Protect against DNA Cross-Links and Other Damages
  Molecular Cell, 1998
• Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation Factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxR
  European Journal Of Cancer, 1998
• Pegaspargase: An Alternative?
  Annals of Pharmacotherapy, 1997
• Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage
  British Journal of Cancer, 1997
• Mechanisms of apoptotic cell death
  Leukemia, 1997
• Molecular Mechanisms of Multidrug Resistance in Cancer Chemotherapy
  Pathology - Research and Practice, 1996
• Apoptosis in cancer therapy: Crossing the threshold
  Cell, 1994
• Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
  Journal of Immunological Methods, 1983
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
  Biochemistry, 1979